Abstract:Introduction of a standard revised medication chart significantly reduced the frequency of prescribing errors, improved ADR documentation and decreased the potential risks associated with warfarin management. The standard chart has enabled uniform training in medicine management.
“…Over a decade, workers in Brisbane introduced a revised medication chart, audited its before-and-after use in five hospital sites in Queensland (demonstrating a significant fall in prescribing errors) and last year published their analysis of the implementation of their National Inpatient Medication Chart in 22 hospitals nationwide; the prescribing error rate fell by a third. 10,11 While acknowledging a Hawthorn effect -whereby the process of education and implementation may have played a role in reducing error rates in this before-and-after study -the authors comment that the standard format facilitates the education of prescribers, and…”
Section: Rocket Scientists Need Not Applymentioning
“…Over a decade, workers in Brisbane introduced a revised medication chart, audited its before-and-after use in five hospital sites in Queensland (demonstrating a significant fall in prescribing errors) and last year published their analysis of the implementation of their National Inpatient Medication Chart in 22 hospitals nationwide; the prescribing error rate fell by a third. 10,11 While acknowledging a Hawthorn effect -whereby the process of education and implementation may have played a role in reducing error rates in this before-and-after study -the authors comment that the standard format facilitates the education of prescribers, and…”
Section: Rocket Scientists Need Not Applymentioning
“…Standardisation and the resultant uniformity of practice have been shown locally to reduce prescribing and administration errors, 10 and a pilot study involving insulin administration resulted in a reduction of the frequency of hypoglycaemia. 11 The primary aim of this medication initiative was to improve the safety of insulin prescribing and administration in Queensland public hospitals without adversely affecting blood glucose control. Common errors related to insulin that have previously been documented are listed in Box 1.…”
Section: Quality and Safety Interventionsmentioning
Diabetes is common in hospitalised patients and insulin is frequently required for management. Insulin is a high-risk drug, accounting for about 15% of reported medication-related incidents. Despite its complexity, insulin management in hospitals is often undertaken by junior and nonspecialist staff. Improving insulin management requires addressing safe prescribing and administration as well as quality use of insulin. Common errors in insulin use are well documented and can be addressed through form design and enhancing decision support. We undertook to improve insulin management using a locally proven improvement methodology. New forms were developed for intravenous and subcutaneous insulin and blood glucose management. Audited pilot studies in four hospitals confirmed improved insulin management without adversely impacting on overall diabetes management as assessed using Glucometrics. Subsequently, the forms have been introduced to 70% of Queensland public hospitals with roll-out to remaining hospitals continuing. Large-scale standardisation of insulin manage-
“…But multiple designs of cockpits or prescription charts can lead to unnecessary errors, however good the background knowledge is. Though the NHS Chief Pharmacist has not supported UK standardization, research from Australia showed benefits [2]. The variability of the available systems with a lack of minimum standards is a problem.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.